US-headquartered biotech firm Recursion has announced that it will acquire UK-based pharmatech Exscientia in an all-stock deal. The transaction, which is expected to...
UK-based pharmatech Exscientia has entered into a binding agreement to buy Vienna-based Allcyte, a specialist in precision medicine using artificial intelligence (AI)...
10.07.2017
- UK drugmaker GlaxoSmithKline (GSK) is to collaborate with artificial intelligence (AI) company Exscientia. The partnership will see Exscientia combine its AI-enabled platform with...
10.05.2017
- French pharma company Sanofi has signed a research collaboration and license option agreement with Scottish drug design company Exscientia that focuses on metabolic diseases such...
